The National Institutes of Health (NIH) Sexual & Gender Minority Research Listening Session, 67748 [2020-23589]

Download as PDF 67748 Federal Register / Vol. 85, No. 207 / Monday, October 26, 2020 / Notices Contact Person: Kenneth A Roebuck, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 20892, (301) 435– 1166, roebuckk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Receptors and Cell Cycle. Date: November 23, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kevin Czaplinski, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892. (301) 435–0000, czaplinskik2@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 20, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–23583 Filed 10–23–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health The National Institutes of Health (NIH) Sexual & Gender Minority Research Listening Session AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) will be holding its second annual listening session with Sexual & Gender Minority (SGM)-focused organizations. The primary objective of the NIH’s listening session is to hear from community stakeholders about what issues are on their minds regarding SGM-related research and related activities at NIH. The goal is to hold an annual listening session every year, to provide different SGM focused organizations an opportunity to speak. DATES: The listening session with the SGM community will be held on November 19, 2020, at 1:00 p.m. ET. ADDRESSES: The meeting will be held virtually as a WebEx Event, and it will be open to the public to listen. Information about the meeting and registration to attend are at this link: SUMMARY: VerDate Sep<11>2014 17:31 Oct 23, 2020 Jkt 253001 https://dpcpsi.nih.gov/sgmro/listeningsession. FOR FURTHER INFORMATION CONTACT: Irene Avila, Ph.D., Assistant Director, Sexual & Gender Minority Research Office (SGMRO), 6555 Rock Spring Drive, Rm. 2SE31J, Bethesda, MD 20817, avilai@mail.nih.gov, 301–594–9701. SUPPLEMENTARY INFORMATION: ‘‘Sexual and gender minority’’ is an umbrella term that includes, but is not limited to, individuals who identify as lesbian, gay, bisexual, asexual, transgender, TwoSpirit, queer, and/or intersex. Individuals with same-sex or -gender attractions or behaviors and those with a difference in sex development are also included. These populations also encompass those who do not selfidentify with one of these terms but whose sexual orientation, gender identity or expression, or reproductive development is characterized by nonbinary constructs of sexual orientation, gender, and/or sex. In accordance with Section 404N of the 21st Century Cures Act (Pub. L. 114– 255), the Sexual and Gender Minority Research Office (SGMRO) coordinates sexual and gender minority (SGM)related research and activities by working directly with NIH Institutes, Centers, and Offices. The Office was officially established in September 2015 within the NIH Division of Program Coordination, Planning, and Strategic Initiatives in the Office of the Director. The SGMRO has the following operational goals: (1) Advance rigorous research on the health of SGM populations in both the extramural and intramural research communities; (2) expand SGM health research by fostering partnerships and collaborations with a strategic array of internal and external stakeholders; (3) foster a highly skilled and diverse workforce in SGM health research; and (4) encourage data collection related to SGM populations in research and the biomedical research workforce. Listening Session Details The listening session event will be an NIH-wide effort, with representation from the SGMRO and other NIH Institutes, Centers, and Offices. The listening session will be open to the public to listen in; comments submitted via email will be accepted post-listening session. The session will be recorded a posted on the SGMRO website approximately one month post-session. Comments, questions, or feedback can be shared with SGMRO@nih.gov. SGMRO will invite approximately 13 SGM-focused organizations to present at the listening session. Selection of the PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 organizations will be based on the diversity of their missions and efforts. Dated: October 19, 2020. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2020–23589 Filed 10–23–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; R13 Conference Grant Review. Date: November 12, 2020. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W552, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Jeanette Irene Marketon, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W552, Rockville, MD 20892, (240) 276–6780, jeanette.marketon@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Smoking Cessation & HIV R01/R21. Date: November 19, 2020. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W102, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Shakeel Ahmad, Ph.D., Chief, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Rockville, MD 20850, 240–276–6442, ahmads@mail.nih.gov. E:\FR\FM\26OCN1.SGM 26OCN1

Agencies

[Federal Register Volume 85, Number 207 (Monday, October 26, 2020)]
[Notices]
[Page 67748]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23589]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


The National Institutes of Health (NIH) Sexual & Gender Minority 
Research Listening Session

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Institutes of Health (NIH) Sexual & Gender 
Minority Research Office (SGMRO) will be holding its second annual 
listening session with Sexual & Gender Minority (SGM)-focused 
organizations. The primary objective of the NIH's listening session is 
to hear from community stakeholders about what issues are on their 
minds regarding SGM-related research and related activities at NIH. The 
goal is to hold an annual listening session every year, to provide 
different SGM focused organizations an opportunity to speak.

DATES: The listening session with the SGM community will be held on 
November 19, 2020, at 1:00 p.m. ET.

ADDRESSES: The meeting will be held virtually as a WebEx Event, and it 
will be open to the public to listen. Information about the meeting and 
registration to attend are at this link: https://dpcpsi.nih.gov/sgmro/listening-session.

FOR FURTHER INFORMATION CONTACT: Irene Avila, Ph.D., Assistant 
Director, Sexual & Gender Minority Research Office (SGMRO), 6555 Rock 
Spring Drive, Rm. 2SE31J, Bethesda, MD 20817, [email protected], 301-
594-9701.

SUPPLEMENTARY INFORMATION: ``Sexual and gender minority'' is an 
umbrella term that includes, but is not limited to, individuals who 
identify as lesbian, gay, bisexual, asexual, transgender, Two-Spirit, 
queer, and/or intersex. Individuals with same-sex or -gender 
attractions or behaviors and those with a difference in sex development 
are also included. These populations also encompass those who do not 
self-identify with one of these terms but whose sexual orientation, 
gender identity or expression, or reproductive development is 
characterized by non-binary constructs of sexual orientation, gender, 
and/or sex.
    In accordance with Section 404N of the 21st Century Cures Act (Pub. 
L. 114-255), the Sexual and Gender Minority Research Office (SGMRO) 
coordinates sexual and gender minority (SGM)-related research and 
activities by working directly with NIH Institutes, Centers, and 
Offices. The Office was officially established in September 2015 within 
the NIH Division of Program Coordination, Planning, and Strategic 
Initiatives in the Office of the Director.
    The SGMRO has the following operational goals: (1) Advance rigorous 
research on the health of SGM populations in both the extramural and 
intramural research communities; (2) expand SGM health research by 
fostering partnerships and collaborations with a strategic array of 
internal and external stakeholders; (3) foster a highly skilled and 
diverse workforce in SGM health research; and (4) encourage data 
collection related to SGM populations in research and the biomedical 
research workforce.

Listening Session Details

    The listening session event will be an NIH-wide effort, with 
representation from the SGMRO and other NIH Institutes, Centers, and 
Offices. The listening session will be open to the public to listen in; 
comments submitted via email will be accepted post-listening session. 
The session will be recorded a posted on the SGMRO website 
approximately one month post-session. Comments, questions, or feedback 
can be shared with [email protected]. SGMRO will invite approximately 13 
SGM-focused organizations to present at the listening session. 
Selection of the organizations will be based on the diversity of their 
missions and efforts.

    Dated: October 19, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2020-23589 Filed 10-23-20; 8:45 am]
BILLING CODE 4140-01-P